F-group (family)
2007.2.1.2 Flavodoxin_2
Ligands and drugs
778
Member domains
385
with ligand contacts (≤ 4 Å)
49.5% of members
351
with DrugDomain annotations
45.1% of members
348
with a DrugBank compound
44.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.2.1.2 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 242 |
| DB03247 | FMN | Flavin mononucleotide | 92 |
| DB04392 | DTC | Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] | 12 |
| DB01065 | ML1 | Melatonin | 10 |
| DB02633 | CBD | Cibacron Blue | 8 |
| DB00170 | VK3 | Menadione | 7 |
| DB01927 | DQN | Duroquinone | 6 |
| DB02709 | STL | Resveratrol | 6 |
| DB04253 | CB1 | Tretazicar | 6 |
| DB00608 | CLQ | Chloroquine | 4 |
| DB02395 | E09 | 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol | 4 |
| DB02400 | 936 | ES-936 | 4 |
| DB03297 | PMS | Benzylsulfonic acid | 4 |
| DB03309 | NHE | N-cyclohexyltaurine | 4 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 4 |
| DB03626 | 340 | 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione | 4 |
| DB04090 | RH1 | RH-1 | 4 |
| DB04719 | K25 | DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE | 4 |
| DB07385 | ARH | 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE | 4 |
| DB08190 | ML2 | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 275 |
| ZNmetal | ZINC ION | 147 |
| FMN | FLAVIN MONONUCLEOTIDE | 95 |
| DTC | BISHYDROXY[2H-1-BENZOPYRAN-2-ONE,1,2-BENZOPYRONE] | 12 |
| E6A | (2~{R},3~{R})-2-[(2~{S},3~{S})-3-bromanyl-1,4-bis(oxidanylidene)-2,3-dihydronaphthalen-2-yl]-3-oxidanyl-2,3-dihydronaphthalene-1,4-dione | 11 |
| EHL | 5-methyl-N-(5-nitro-1,3-thiazol-2-yl)-3-phenyl-1,2-oxazole-4-carboxamide | 11 |
| ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | 10 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 10 |
| CBD | CIBACRON BLUE | 8 |
| CC2 | 4-hydroxy-6,7-dimethyl-3-(naphthalen-1-ylmethyl)-2H-chromen-2-one | 8 |
| CL | CHLORIDE ION | 8 |
| 1IE | ~{N}-(3-methylsulfanylphenyl)-4~{H}-cyclopenta[b]quinolin-9-amine | 7 |
| CB1 | 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE | 6 |
| DQN | DUROQUINONE | 6 |
| STL | RESVERATROL | 6 |
| VK3 | MENADIONE | 6 |
| 05G | 6-hydroxy-5-[(E)-(2-methoxy-5-methyl-4-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid | 4 |
| 340 | 5-METHOXY-1,2-DIMETHYL-3-(PHENOXYMETHYL)INDOLE-4,7-DIONE | 4 |
| 936 | 5-METHOXY-1,2-DIMETHYL-3-(4-NITROPHENOXYMETHYL)INDOLE-4,7-DIONE | 4 |
| 978 | ~{N}-[4-[(3-methylphenyl)carbonylamino]phenyl]-5-nitro-furan-2-carboxamide | 4 |